Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CMI vs GSK✓SelectedUSD · GSKCMI vs GSK performance historyLatest closeAs of-1.57%11/18
Stock and ETF performance explorer

CMI vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-36.6%
GSK return
-0.7%
Excess return
-35.9%
Maximum drawdown
-41.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.6%-1.3%-0.2%-1.9%
7D-7.8%-3.1%-4.7%-8.6%
30D-18.2%-0.9%-17.3%-18.0%
3M-30.9%-4.2%-26.8%-31.2%
6M-36.6%-1.6%-35.0%-36.2%
All-36.6%-0.7%-35.9%-36.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling